Convenient & Travel-Friendly: Individually packaged strips fit discreetly in your pocket or purse
Target the joint
Every vial ships with a free one buy 3 get 3, buy 10 get 10
For this product page, the practical identity signals are the stated peptide name, sequence, vial configuration, lyophilized format, and supporting analytical documents
Tirzepatide is an FDA-approved prescription medication marketed as Mounjaro for type 2 diabetes mellitus and Zepbound for chronic weight management in adults with BMI 30 kg/m, or 27 kg/m with at least one weight-related comorbidity
Figure 2: Categorical weight loss of either 5%, 10%, or 15% in the randomly assigned treatment groups administered either 0.3 mg of cagrilintide, 0.6 mg of cagrilintide, 1.2 mg of cagrilintide, 2.5 mg of cagrilintide, 4.5 mg of cagrilintide, 3.0 mg of liraglutide, or a placebo